OPERATING ASSETS:

1. PERSONALIZ3D™: Personalized medicine platform designed to integrate telehealth, pharmaceutical 3D printing, and qualified pharmacy fulfillment.
2. KetaMist®: Needle-free ketamine solution.

​MONETIZING ASSETS:

1. Psychedelics: KetaRx™ Ketamine (FDA-approved), KetaVault™ (proprietary data), Ketamine clinical portfolio, and PharmaPATCH™ (Ketamine, Psilocybin, MDMA, LSD, DMT).
2. Investments: Sairiyo Therapeutics Inc. (Patented reformulated cepharanthine).